How many employees does Epizyme have this year?
Epizyme has 304 undefined employees this year.
Epizyme Employees 2024
Epizyme Employees
304
Ticker
EPZM
ISIN
US29428V1044
WKN
A1T9L2
In 2024, Epizyme employed 304 people, a 0% change from the 0 number of employees in the previous year.
Epizyme Aktienanalyse
What does Epizyme do?
Epizyme Inc is an American biotechnology company specializing in the development of therapeutic products for the treatment of cancer and genetic metabolic disorders. The company was founded in 2007 in Cambridge, Massachusetts. Epizyme focuses on developing drugs that target epigenetic changes in cells, which are changes in gene expression caused by changes in DNA structure. Epizyme specializes in the development of inhibitors of histone deacetylase enzymes (HDAC), which suppress the activity of enzymes involved in cell cycle regulation, apoptosis, and DNA repair. The company is divided into different business units focusing on different therapy areas, including oncology, hematologic oncology, and genetic metabolic disorders. In the field of oncology, Epizyme develops drugs for the treatment of blood and lymphatic system cancers such as diffuse large B-cell lymphoma and T-cell lymphoma. In the field of hematologic oncology, the company develops drugs for the treatment of blood disorders like myelodysplastic syndrome and acute myeloid leukemia. In the field of genetic metabolic disorders, Epizyme develops drugs for the treatment of lysosomal storage diseases. The company's business model primarily involves developing its own therapy products and collaborating with other biopharmaceutical companies and the pharmaceutical industry. Epizyme is listed on NASDAQ under the ticker symbol EPZM and has raised over $230 million in funding. Overall, Epizyme is an innovative company with a promising pipeline of drug candidates that works closely with other industry players to achieve its goals. It has established itself as a key player in the biotechnology industry. Epizyme ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Epizyme's Employee Base
Epizyme's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Epizyme's operational capacity and future potential.
Year-to-Year Comparison
Assessing Epizyme's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Epizyme's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Epizyme’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Epizyme stock
How many employees did Epizyme have compared to the previous year?
Compared to the previous year, Epizyme had 0% more employees.
What impact did the number of employees have on the company Epizyme?
The number of employees has a direct impact on the efficiency and productivity of Epizyme. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Epizyme?
The number of employees can also have an impact on investors of Epizyme, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Epizyme affect the company?
An increase in equity of Epizyme can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Epizyme's equity affect the company?
A reduction in equity of Epizyme can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Epizyme?
Some factors that can influence the equity of Epizyme include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Epizyme so important for investors?
The equity of Epizyme is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Epizyme influence the company?
The number of employees at Epizyme can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Epizyme evolved in recent years?
In recent years, the number of employees at Epizyme has changed by NaN.
How many employees does Epizyme currently have?
Epizyme currently has 304 undefined employees.
Why is the number of employees important for investors of Epizyme?
The number of employees is important for investors of Epizyme as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Epizyme take to change the number of employees?
To change the number of employees, Epizyme can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Epizyme pay?
Over the past 12 months, Epizyme paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Epizyme is expected to pay a dividend of 0 USD.
What is the dividend yield of Epizyme?
The current dividend yield of Epizyme is .
When does Epizyme pay dividends?
Epizyme pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Epizyme?
Epizyme paid dividends every year for the past 0 years.
What is the dividend of Epizyme?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Epizyme located?
Epizyme is assigned to the 'Health' sector.
Wann musste ich die Aktien von Epizyme kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Epizyme from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.
When did Epizyme pay the last dividend?
The last dividend was paid out on 9/30/2024.
What was the dividend of Epizyme in the year 2023?
In the year 2023, Epizyme distributed 0 USD as dividends.
In which currency does Epizyme pay out the dividend?
The dividends of Epizyme are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Epizyme stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Epizyme
Our stock analysis for Epizyme Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Epizyme Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
